Tone mix
Week by week 52 weeks
Share of Vertex Pharmaceuticals Inc's 450 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Jul 20, 2026 · tone +98Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching+59
- Week of Apr 27, 2026 · tone -18Vertex Pharmaceuticals Incorporated (VRTX) PT Nudged Higher as RBC Updates Biotech Sector Outlook-57
- Week of Aug 10, 2026 · tone -14One Company's Clinical Miss Is Another's Moat: Vertex Rallies as Sionna's CF Bet Collapses-53
- Week of Feb 2, 2026 · tone +72WuXi Biologics Jumps On Pact With Vertex Pharma For T-Cell Engager In Autoimmune Disease+48
- Week of Mar 30, 2026 · tone +75Wells Fargo Raises Vertex Pharmaceuticals (VRTX) Price Target to $550+44
- Week of Oct 12, 2026 · tone -4Vertex Pharmaceuticals VRTX Drops 4.1%, Shedding ~$5 Billion in One Session-38
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about Vertex Pharmaceuticals Inc in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 9 | +32 |
| Last 30 sessions | 31 | +29 |
| Last 90 sessions | 128 | +37 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone +100: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.propertyweek.com · 1 outletVertex Pharma wins grant to build 155,000 sq ft facility at Harwell Campus in OxonPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vertex Pharma wins grant to build 155,000 sq ft facility at Harwell Campus in Oxon | www.propertyweek.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
2 headlines, average tone 0: 0 positive, 2 neutral and 0 negative. Showing all 2.
- www.fool.com · 2 outletsAmgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug RevenueNeutral
- www.themarketsdaily.com · 1 outletVertex Pharmaceuticals Incorporated $VRTX Stock Position Boosted by Sigma Planning CorpNeutral
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Amgen vs. Vertex Pharmaceuticals: Massive Pharmaceutical Scale vs. Steady Drug Revenue | www.fool.com | 2 | Neutral |
| Vertex Pharmaceuticals Incorporated $VRTX Stock Position Boosted by Sigma Planning Corp | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Monday, October 26, 2026
2 headlines, average tone +50: 1 positive, 1 neutral and 0 negative. Showing all 2.
- www.fool.com · 2 outletsVertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change.Neutral
- www.finanznachrichten.de · 1 outletVertex Pharmaceuticals Incorporated: Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026Positive
Show the table · 2 rows, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vertex Pharmaceuticals Gets 96% of Product Sales From Treatments for 1 Disease. Here's Why That's About to Change. | www.fool.com | 2 | Neutral |
| Vertex Pharmaceuticals Incorporated: Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 2026 | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 23, 2026
1 headline, average tone -100: 0 positive, 0 neutral and 1 negative. Showing all 1.
- www.dailypolitical.com · 1 outletErste Group Bank Analysts Lower Earnings Estimates for VRTXNegative
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Erste Group Bank Analysts Lower Earnings Estimates for VRTX | www.dailypolitical.com | 1 | Negative |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 22, 2026
1 headline, average tone +94: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.insidermonkey.com · 1 outletVertex Pharmaceuticals' New Drugs Are Gaining Ground. Is That Enough for Investors?Positive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Vertex Pharmaceuticals' New Drugs Are Gaining Ground. Is That Enough for Investors? | www.insidermonkey.com | 1 | Positive |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about Vertex Pharmaceuticals Inc, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.